These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 1444323)

  • 1. Zidovudine inhibits hepatitis B virus replication.
    Berk L; Schalm SW; Heijtink RA
    Antiviral Res; 1992 Aug; 19(2):111-8. PubMed ID: 1444323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. No effect of zidovudine on hepatitis B virus replication in homosexual men with symptomatic HIV-1 infection.
    Gilson RJ; Hawkins AE; Kelly GK; Gill SK; Weller IV
    AIDS; 1991 Feb; 5(2):217-20. PubMed ID: 2031694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Inhibition of replication of human hepatitis B virus].
    Tsibinogin VV; Kraevskiĭ AA; Bibilashvili RSh; Gren EIa; Kiselev LL
    Mol Biol (Mosk); 1989; 23(4):983-7. PubMed ID: 2586511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absence of effect of zidovudine on replication of hepatitis B virus in patients with chronic HIV and HBV infection.
    Marcellin P; Pialoux G; Girard PM; Boyer N; Martinot-Peignoux M; Loriot MA; Dazza MC; Benhamou JP
    N Engl J Med; 1989 Dec; 321(25):1758. PubMed ID: 2594033
    [No Abstract]   [Full Text] [Related]  

  • 5. Preliminary evidence that azidothymidine does not affect hepatitis B virus replication in acquired immunodeficiency syndrome (AIDS) patients.
    Farraye FA; Mamish DM; Zeldis JB
    J Med Virol; 1989 Dec; 29(4):266-7. PubMed ID: 2621453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acyclovir enhances the antiviral effect of interferon in chronic hepatitis B.
    Schalm SW; Heytink RA; van Buuren HR; de Man RA
    Lancet; 1985 Aug; 2(8451):358-60. PubMed ID: 2862516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of 3'-azido-3'-deoxythymidine on replication of duck hepatitis B virus in vivo and in vitro.
    Haritani H; Uchida T; Okuda Y; Shikata T
    J Med Virol; 1989 Dec; 29(4):244-8. PubMed ID: 2559951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of hepatitis B virus DNA polymerase by 3'-azido-3'-deoxythymidine triphosphate but not by its threo analog.
    Nordenfelt E; Löfgren B; Chattopadhyaya J; Oberg B
    J Med Virol; 1987 Jul; 22(3):231-6. PubMed ID: 3476686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sequential combination therapy leads to biochemical and histological improvement despite low ongoing intrahepatic hepatitis B virus replication.
    Lutgehetmann M; Volzt T; Quaas A; Zankel M; Fischer C; Dandri M; Petersen J
    Antivir Ther; 2008; 13(1):57-66. PubMed ID: 18389899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro susceptibility of lamivudine-resistant hepatitis B virus to adefovir and tenofovir.
    Lada O; Benhamou Y; Cahour A; Katlama C; Poynard T; Thibault V
    Antivir Ther; 2004 Jun; 9(3):353-63. PubMed ID: 15259898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The mechanism of inhibition of hepatitis B virus replication by the carbocyclic analog of 2'-deoxyguanosine.
    Price PM; Banerjee R; Jeffrey AM; Acs G
    Hepatology; 1992 Jul; 16(1):8-12. PubMed ID: 1319957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon-alpha and zidovudine combination therapy for chronic hepatitis B: results of a randomized, placebo-controlled trial.
    Janssen HL; Berk L; Heijtink RA; ten Kate FJ; Schalm SW
    Hepatology; 1993 Mar; 17(3):383-8. PubMed ID: 8444411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced oral absorption and antiviral activity of 1-O-octadecyl-sn-glycero-3-phospho-acyclovir and related compounds in hepatitis B virus infection, in vitro.
    Hostetler KY; Beadle JR; Kini GD; Gardner MF; Wright KN; Wu TH; Korba BA
    Biochem Pharmacol; 1997 Jun; 53(12):1815-22. PubMed ID: 9256156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of human hepatitis B virus DNA polymerase and duck hepatitis B virus DNA polymerase by triphosphates of thymidine analogs and pharmacokinetic properties of the corresponding nucleosides.
    Tao PZ; Löfgren B; Lake-Bakaar D; Johansson NG; Datema R; Oberg B
    J Med Virol; 1988 Dec; 26(4):353-62. PubMed ID: 3145322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitation of hepatitis B viral DNA by solution hybridization: comparison with DNA polymerase and hepatitis B e antigen during antiviral therapy.
    Kuhns MC; McNamara AL; Perrillo RP; Cabal CM; Campbel CR
    J Med Virol; 1989 Apr; 27(4):274-81. PubMed ID: 2656908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of the replication of hepatitis B virus by the carbocyclic analogue of 2'-deoxyguanosine.
    Price PM; Banerjee R; Acs G
    Proc Natl Acad Sci U S A; 1989 Nov; 86(21):8541-4. PubMed ID: 2813411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persistence of hepatitis B virus DNA after reduction of viral replication in serum and liver.
    Molina J; Bartolomé J; Moraleda G; Ruiz-Moreno M; Rua MJ; Moreno A; Carreño V
    J Med Virol; 1992 Sep; 38(1):11-5. PubMed ID: 1383416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transgenic mice as a chemotherapeutic model for hepatitis B virus infection.
    Morrey JD; Korba BE; Sidwell RW
    Antivir Ther; 1998; 3(Suppl 3):59-68. PubMed ID: 10726056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acyclovir, oral, intravenous and combined with interferon for chronic HBeAg-positive hepatitis.
    Schalm SW; Heytink RA; Van Buuren HR; De Man RA
    J Hepatol; 1986; 3 Suppl 2():S137-41. PubMed ID: 3598154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does treatment of hepatitis B virus (HBV) infection reduce hepatitis delta virus (HDV) replication in HIV-HBV-HDV-coinfected patients?
    Sheldon J; Ramos B; Toro C; Ríos P; Martínez-Alarcón J; Bottecchia M; Romero M; Garcia-Samaniego J; Soriano V
    Antivir Ther; 2008; 13(1):97-102. PubMed ID: 18389903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.